Value of drug or valuable drug: a point of view issue

Authors

  • Francesca Patarnello Payers and Evidence Solution Director, Access to Medicine. GlaxoSmithKline Spa – Pharmaceuticals, Verona, Italy

DOI:

https://doi.org/10.7175/fe.v13i4.329

Keywords:

Drugs, Value, Costs, Pharmacoeconomics

Downloads

Published

2012-12-15

Issue

Section

Editorial

How to Cite

Value of drug or valuable drug: a point of view issue. (2012). Farmeconomia. Health Economics and Therapeutic Pathways, 13(4), 155-157. https://doi.org/10.7175/fe.v13i4.329